Diphenan

Diphenan

SCHEMBL667724

NC(=O)Oc1ccc(Cc2ccccc2)cc1

nearest known ligand 0.58

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G10 O15496 1/20 0.58
PLA2G2A P14555 1/20 0.58
LTA4H P09960 5/20 0.52
PPARG P37231 3/20 0.51
PPARA Q07869 3/20 0.51
SRD5A2 P31213 1/20 0.51
ELANE P08246 1/20 0.50
LMNA P02545 2/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
CA9 Q16790 1/20 0.48
SLC22A2 O15244 1/20 0.47
ASAH1 Q13510 1/20 0.47
MAPK1 P28482 1/20 0.46
CASP3 P42574 1/20 0.46
SENP7 Q9BQF6 1/20 0.46
SENP6 Q9GZR1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9542970 0.92 ELANE (0.57) PLA2G10PLA2G2APPARGPPARASRD5A2
SCHEMBL5478152 0.84 LTA4H (0.55) PLA2G10PLA2G2ALTA4HPPARGPPARA
SCHEMBL6224844 0.84 LTA4H (0.55) PLA2G10PLA2G2ALTA4HPPARGPPARA
SCHEMBL4682259 0.83 ELANE (0.53) SRD5A2ELANELMNAMEN1KMT2A
SCHEMBL4246486 0.83 KMT2A (0.55) LTA4HELANELMNAMEN1KMT2A
SCHEMBL8060201 0.82 SRD5A2 (0.58) PLA2G10PLA2G2ALTA4HPPARGPPARA
SCHEMBL5799798 0.81 PARP10 (0.70) LTA4HSRD5A2LMNACA12CA1
SCHEMBL29260073 0.81 CYP17A1 (0.56) LTA4HELANELMNAMEN1KMT2A
Carbamic Acid Phenyl Ester SCHEMBL7566 0.81 MEN1 (0.70) MEN1KMT2AL3MBTL1PARP10
SCHEMBL8459616 0.81 LTA4H (0.52) PLA2G10PLA2G2ALTA4HPPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12531245-B2 Lithium-ion secondary battery TDK CORPORATION (JP) 2026-01-20 US claimed
CN-115960665-A Method for preparing lubricating oil composition and regulating or determining electrical insulation property of lubricating oil composition 中国石油化工股份有限公司 2023-04-14 CN claimed
US-20230080975-A1 LITHIUM-ION SECONDARY BATTERY TDK CORPORATION (JP) 2023-03-16 US claimed
WO-2022138432-A1 THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL 東レ株式会社 2022-06-30 WO claimed
WO-2022124191-A1 THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE FROM THERMOSETTING EPOXY RESIN, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIAL, FIBER-REINFORCED COMPOSITE MATERIAL, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL 東レ株式会社 2022-06-16 WO claimed
WO-2022102467-A1 THERMOSETTING EPOXY RESIN COMPOSITION, MOLDED ARTICLE OF SAME, FIBER-REINFORCED COMPOSITE MATERIAL, MOLDING MATERIAL FOR FIBER-REINFORCED COMPOSITE MATERIALS, AND METHOD FOR PRODUCING FIBER-REINFORCED COMPOSITE MATERIAL 東レ株式会社 2022-05-19 WO claimed
CN-114181051-A Preparation method and application of peach carin phenol 广州杨森药业有限公司 2022-03-15 CN claimed
CN-113960138-A Construction method and application of biosensor for simultaneously measuring omethoate and acetamiprid 江南大学 2022-01-21 CN claimed
WO-2021261176-A1 SOLAR CELL パナソニックIPマネジメント株式会社 2021-12-30 WO claimed
WO-2021065099-A1 COPOLYMER, CURABLE RESIN COMPOSITION, AND CURED PRODUCT 株式会社ダイセル 2021-04-08 WO claimed
US-9016221-B2 Surface topographies for non-toxic bioadhesion control UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2015-04-28 US claimed
US-20140370110-A1 POLYMER CONJUGATED PROTEIN MICELLES SOUTH DAKOTA STATE UNIVERSITY (US) 2014-12-18 US claimed
US-20100226943-A1 SURFACE TOPOGRAPHIES FOR NON-TOXIC BIOADHESION CONTROL UNIVERSITY OF FLORIDA (US) 2010-09-09 US claimed
CN-101330905-A Freeze-drying process and products obtained thereby SCIDOSE LLC (US) 2008-12-24 CN claimed
EP-1954244-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY Scidose, Llc (US) 2008-08-13 EP claimed
WO-2007061529-A1 LYOPHILIZATION PROCESS AND PRODUCTS OBTAINED THEREBY SCIDOSE LLC. (US) 2007-05-31 WO claimed
US-20070116729-A1 Lyophilization process and products obtained thereby SCIDOSE LLC 2007-05-24 US claimed
CN-1294519-A Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient INPHARMA SA (CH) 2001-05-09 CN claimed
EP-1073470-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2001-02-07 EP claimed
WO-2000048636-A1 PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS INPHARMA S.A. (CH) 2000-08-24 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12531245-B2 Lithium-ion secondary battery CACNA2D1, KCNN2, SCN2B PLA2G10 3404/4885PLA2G2A 3377/4885LTA4H 3810/4885
US-20140370110-A1 POLYMER CONJUGATED PROTEIN MICELLES MTDH, PSMG3, GHITM PLA2G10 1316/4885PLA2G2A 1640/4885LTA4H 3353/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.